Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Brnabic, A"" wg kryterium: Autor


Tytuł:
Incidence of type 2 diabetes, cardiovascular disease and chronic kidney disease in patients with multiple sclerosis initiating disease-modifying therapies: Retrospective cohort study using a frequentist model averaging statistical framework.
Autorzy:
Brnabic, Alan J. M. (AUTHOR)
Curtis, Sarah E. (AUTHOR)
Johnston, Joseph A. (AUTHOR)
Lo, Albert (AUTHOR)
Zagar, Anthony J. (AUTHOR)
Lipkovich, Ilya (AUTHOR)
Kadziola, Zbigniew (AUTHOR)
Murray, Megan H. (AUTHOR)
Ryan, Timothy (AUTHOR)
Pokaż więcej
Źródło:
PLoS ONE. 3/22/2024, Vol. 19 Issue 3, p1-14. 14p.
Czasopismo naukowe
Tytuł:
Incidence of type 2 diabetes, cardiovascular disease and chronic kidney disease in patients with multiple sclerosis initiating disease-modifying therapies: Retrospective cohort study using a frequentist model averaging statistical framework.
Autorzy:
Alan J M Brnabic
Sarah E Curtis
Joseph A Johnston
Albert Lo
Anthony J Zagar
Ilya Lipkovich
Zbigniew Kadziola
Megan H Murray
Timothy Ryan
Pokaż więcej
Temat:
Medicine
Science
Źródło:
PLoS ONE, Vol 19, Iss 3, p e0300708 (2024)
Opis pliku:
electronic resource
Relacje:
https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0300708&type=printable; https://doaj.org/toc/1932-6203
Dostęp URL:
https://doaj.org/article/0d5a1ab4d7554a9784f75d42f490719a  Link otwiera się w nowym oknie
Czasopismo naukowe
Tytuł:
Comparative Effectiveness and Durability of Biologics in Clinical Practice: Month 12 Outcomes from the International, Observational Psoriasis Study of Health Outcomes (PSoHO).
Autorzy:
Pinter A; University Hospital Frankfurt, Frankfurt am Main, Germany. .
Costanzo A; Division of Dermatology, Humanitas Research Hospital, Pieve Emanuele, Milan, Italy.; Dermatology IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.
Khattri S; Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Smith SD; ANU Medical School, ANU College of Health and Medicine, The Australian National University, Canberra, Australia.
Carrascosa JM; Department of Dermatology, Hospital Universitari Germans Trias i Pujol, Universitat Autònoma of Barcelona, IGTP, Carretera de Canyet, S/N, 08916, Badalona, Barcelona, Spain.
Tada Y; Department of Dermatology, Teikyo University School of Medicine, Tokyo, Japan.
Riedl E; Department of Dermatology, Medical University of Vienna, Vienna, Austria.
Reich A; Department of Dermatology, Institute of Medical Sciences, Medical College of Rzeszow University, Rzeszow, Poland.
Brnabic A; Eli Lilly and Company, Indianapolis, USA.
Haustrup N; Eli Lilly and Company, Indianapolis, USA.
Lampropoulou A; Eli Lilly and Company, Indianapolis, USA.
Lipkovich I; Eli Lilly and Company, Indianapolis, USA.
Kadziola Z; Eli Lilly and Company, Indianapolis, USA.
Paul C; Université Paul Sabatier Toulouse III, Toulouse, France.
Schuster C; Department of Dermatology, Medical University of Vienna, Vienna, Austria.; Eli Lilly and Company, Indianapolis, USA.
Pokaż więcej
Źródło:
Dermatology and therapy [Dermatol Ther (Heidelb)] 2023 Dec 19. Date of Electronic Publication: 2023 Dec 19.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Comparative Effectiveness, Time to Discontinuation, and Patient-Reported Outcomes with Baricitinib in Rheumatoid Arthritis: 2-Year Data from the Multinational, Prospective Observational RA-BE-REAL Study in European Patients.
Autorzy:
Alten, Rieke
Burmester, Gerd R.
Matucci-Cerinic, Marco
Salmon, Jean-Hugues
Östör, Andrew
Ng, Khai Jing
Gerwien, Jens
Zaremba-Pechmann, Liliana
Brnabic, Alan J. M.
Fautrel, Bruno
Pokaż więcej
Temat:
RHEUMATOID arthritis
BARICITINIB
DISEASE remission
TERMINATION of treatment
VISUAL analog scale
DRUG efficacy
Źródło:
Rheumatology & Therapy; Dec2023, Vol. 10 Issue 6, p1575-1595, 21p
Czasopismo naukowe
Tytuł:
Effectiveness of Biologics, Patient-Reported Outcomes, and Clinical Photography in a Subset of Patients with Moderate-to-Severe Psoriasis: Week 12 Results from the Psoriasis Study of Health Outcomes (PSoHO).
Autorzy:
Travaglini, Massimo
Maul, Julia-Tatjana
Kors, Christian
Zaheri, Shirin
Gerwien, Jens
Müller, Michaela
Brnabic, Alan
Sabatino, Silvia
Schuster, Christopher
Tsai, Tsen-Fang
Pokaż więcej
Temat:
PATIENT reported outcome measures
BIOLOGICALS
PSORIASIS
PHOTOGRAPHY
QUALITY of life
Źródło:
Clinical, Cosmetic & Investigational Dermatology; Oct2023, Vol. 16, p2971-2983, 13p
Czasopismo naukowe
Tytuł:
42592 Baseline Characteristics and Interim Month 12 mNAPSI Results in Patients with Moderate-to- Severe Plaque Psoriasis and Concomitant Nail Psoriasis Treated with Biologics in the Psoriasis Study of Health Outcomes (PSoHO).
Autorzy:
Egeberg, Alexander
Pinter, Andreas
Vender, Ronald
Zaheri, Shirin
Brnabic, Alan
Schuster, Christopher
Elrayes, Mohamed
Reed, Catherine
Riedl, Elisabeth
Puig, Luis
Pokaż więcej
Źródło:
Journal of the American Academy of Dermatology; 2023 Supplement, Vol. 89 Issue 3, pAB127-AB127, 1p
Czasopismo naukowe
Tytuł:
43054 The Psoriasis Study of Health Outcomes (PSoHO) in biologic-naïve and -experienced patients: A post-hoc analysis of patients receiving treatment according to US labels.
Autorzy:
Khattri, Saakshi
Gooderham, Melinda
Reich, Adam
Lynde, Charles
Malatestinic, William
Reed, Catherine
Brnabic, Alan
Feely, Meghan
Gallo, Gaia
Pinter, Andreas
Pokaż więcej
Źródło:
Journal of the American Academy of Dermatology; 2023 Supplement, Vol. 89 Issue 3, pAB237-AB237, 1p
Czasopismo naukowe
Tytuł:
42900 Understanding comorbidities and concomitant medication patterns in patients with moderate- to-severe plaque psoriasis in the real-world Psoriasis Study of Health Outcomes (PSoHO).
Autorzy:
Puig, Luis
Schäkel, Knut
Reich, Adam
Zaheri, Shirin
Tjioe, Milan
Brnabic, Alan
de Hoog, Niek
Reed, Catherine
Schuster, Christopher
Riedl, Elisabeth
Pokaż więcej
Źródło:
Journal of the American Academy of Dermatology; 2023 Supplement, Vol. 89 Issue 3, pAB245-AB245, 1p
Czasopismo naukowe
Tytuł:
Speed of clinical improvement in the real‐world setting from patient‐reported Psoriasis Symptoms and Signs Diary: Secondary outcomes from the Psoriasis Study of Health Outcomes through 12 weeks.
Autorzy:
Reich, A. (AUTHOR)
Pinter, A. (AUTHOR)
Maul, J.‐T. (AUTHOR)
Vender, R. B. (AUTHOR)
Torres, T. (AUTHOR)
Brnabic, A. (AUTHOR)
Haustrup, N. (AUTHOR)
Reed, C. (AUTHOR)
Schuster, C. (AUTHOR)
Riedl, E. (AUTHOR)
Pokaż więcej
Źródło:
Journal of the European Academy of Dermatology & Venereology. Sep2023, Vol. 37 Issue 9, p1825-1840. 16p.
Czasopismo naukowe
Tytuł:
Comparative Effectiveness, Time to Discontinuation, and Patient-Reported Outcomes with Baricitinib in Rheumatoid Arthritis: 2-Year Data from the Multinational, Prospective Observational RA-BE-REAL Study in European Patients
Autorzy:
Rieke Alten
Gerd R. Burmester
Marco Matucci-Cerinic
Jean-Hugues Salmon
Andrew Östör
Khai Jing Ng
Jens Gerwien
Liliana Zaremba-Pechmann
Alan J. M. Brnabic
Bruno Fautrel
Pokaż więcej
Temat:
Baricitinib
Comparative effectiveness
Real-world evidence
Rheumatoid arthritis
Treatment discontinuation
Diseases of the musculoskeletal system
RC925-935
Źródło:
Rheumatology and Therapy, Vol 10, Iss 6, Pp 1575-1595 (2023)
Opis pliku:
electronic resource
Relacje:
https://doaj.org/toc/2198-6576; https://doaj.org/toc/2198-6584
Dostęp URL:
https://doaj.org/article/63d5ff311b2441d18921c0a0894d1ffb  Link otwiera się w nowym oknie
Czasopismo naukowe
Tytuł:
Comparative Effectiveness of Biologics Across Subgroups of Patients with Moderate-to-Severe Plaque Psoriasis: Results at Week 12 from the PSoHO Study in a Real-World Setting.
Autorzy:
Lynde, Charles
Riedl, Elisabeth
Maul, Julia-Tatjana
Torres, Tiago
Pinter, Andreas
Fabbrocini, Gabrielle
Daniele, Flavia
Brnabic, Alan
Reed, Catherine
Wilhelm, Stefan
Holzkämper, Thorsten
Schuster, Christopher
Puig, Luis
Pokaż więcej
Źródło:
Advances in Therapy; Mar2023, Vol. 40 Issue 3, p869-886, 18p
Czasopismo naukowe
Tytuł:
Managing patients with advanced soft tissue sarcoma: Evolving landscape from an Australian perspective.
Autorzy:
Bae S; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia.
Brnabic A; Eli Lilly Australia, West Ryde, New South Wales, Australia.
Crowe P; Department of Surgery, Prince of Wales Hospital, Randwick, New South Wales, Australia.
Carey-Smith R; Department of Orthopaedic Surgery, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia.
Andelkovic V; Department of Medical Oncology, Princess Alexandra Hospital, Woolloongabba, Queensland, Australia.
Singhal N; Department of Medical Oncology, Royal Adelaide Hospital, Adelaide, South Australia, Australia.
Stalley P; Department of Orthopaedic Surgery, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia.
Yip D; Department of Medical Oncology, The Canberra Hospital, Canberra, Australian Capital Territory, Australia.
Desai J; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia.
Pokaż więcej
Źródło:
Asia-Pacific journal of clinical oncology [Asia Pac J Clin Oncol] 2022 Dec; Vol. 18 (6), pp. 605-613. Date of Electronic Publication: 2022 Jan 30.
Typ publikacji:
Journal Article
MeSH Terms:
Sarcoma*/drug therapy
Soft Tissue Neoplasms*/therapy
Leiomyosarcoma*/pathology
Humans ; Male ; Retrospective Studies ; Victoria/epidemiology
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies